With its unique biased signaling mechanism, Ecnoglutide injection has demonstrated a strong efficacy and safety profile across multiple clinical studies, achieving in Chinese patients 15.1% placebo-adjusted weight loss, 92.8% of patients attaining clinically meaningful weight loss, and over 80% of patients achieving HbA1c levels below 7.0%
Insight into the oxidative stress induced by lead and/or cadmium in blood, liver and kidneys
Neither requires complex reconstitution procedures beyond what any experienced peptide researcher already handles
Among the nine parallel RCTs, five studies (21, 44, 45, 48, 49) demonstrated low risk of bias across all domains, while the remaining four exhibited some concerns or high risk in specific domains (particularly randomization process and deviations from intended interventions)